Cetrelimab ELISA Kit
Product Specifications
Background
Cetrelimab (JNJ-63723283) is an IgG4, anti-programmed cell death protein-1 (PD-1) antibody. Here we present updated results from an ongoing phase 1/2 study of cetrelimab in patients (pts) with advanced or refractory solid cancers.
Specifications
Cetrelimab
Product Name Alternative
JNJ-63723283, CAS: 2050478-92-5
Detection Method
Colorimetric
Assay Type
Quantitative
Sample Type
Plasma, Serum
Detection Range
0.31-5 μg/mL
Recovery
80-120%
Sensitivity
0.156 μg/ml
Shipping Conditions
2-8 °C
Storage Conditions
The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.
Notes
For Research Use Only.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNUM2296-50 1x 50 µL
ACTH (Adrenocorticotrophic Hormone) (Pituitary Marker) (rCLIP/1407), 1mg/mL
Sign In for Pricing
View Details 
BNC880261-100 1x 100 µL
CD66 (CEA) (C66/261), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
TRC-G419135-5MG 5 mg
6-Alpha-D-Glucopyranosyl Maltotriose Tridecaacetate
Sign In for Pricing
View Details